About Us
About OnCusp
Culture and Values
Management Team
Scientific Advisory Board
Company Milestones
R&D
Strategy
Company Pipeline
Partnership
Business Development Approach
Our Top Investors
Newsroom
Company News
Coverage
Publications
Careers
Careers
Join Our Team
Job Opportunities
Contact
CN
For Chinese biotechs, the out-licensing business is scorching hot. Could geopolitics rain on their parade?
Apr 11, 2024
Prev article :OnCusp: Bing Yuan’s newco to provide bridge from innovation to MNC（by BioCentury）
Back
